Not only is lung cancer the leading cause of cancer deaths among females and males, but it’s also the most common type of cancer. Despite its high prevalence and mortality rates, communicative care between non-small cell lung cancer (NSCLC) patients and their providers is still unfortunately lacking. In an effort to both address and resolve this disparity, Closing the Gaps in NSCLC will focus on the latest guidelines and the current therapeutic landscape within NSCLC. This non-certified educational series is sponsored by Lilly. Content for this series is produced and controlled by ReachMD. This series is intended for healthcare professionals only. Sponsored by
Host: Jennifer Caudle, DO Guest: Stephen Liu, MD To help us treat the disease representing the most common cause of cancer mortality worldwide—with mo...
Guest: Stephen Liu, MD Immune checkpoint inhibitors are now the standard of care for almost all of our patients with non-small cell lung cancer. And h...
Guest: Amit Bobby Mahajan, MD, FCCP, DAABIP Lung cancer is known to be the deadliest and second most common cancer in men and women. Although there cu...
Host: Paul Doghramji, MD Guest: Tony Y. Hu, PhD Since treatment outcomes vary greatly between lung cancer patients—even among those who are diagnosed ...
Host: Paul Doghramji, MD Guest: Tony Y. Hu, PhD One of the biggest blindspots for those who care for patients with lung cancer is not knowing whose di...
Guest: Michael R. Shafique, MD After many decades of trying to improve the outcomes of patients with advanced non-small cell lung cancer, we may final...
Guest: Michael R. Shafique, MD The therapies that have been approved for non-small cell lung cancer stimulate the immune system to attack cancer cells...
Guest: Edward S. Kim, MD When looking at the non-small cell lung cancer landscape, we’re now seeing the emergence of several genetic markers that may ...
Host: Paul P. Doghramji, MD, FAAFP Guest: Edward S. Kim, MD Thanks to recent research, we can now use a non-small cell cancer patient’s cancer type an...
Guest: Deepa Rangachari, MD Communication is the key to guiding patients with non-small cell lung cancer through testing and treatment, but what exact...